67 related articles for article (PubMed ID: 17091277)
1. In situ depletion of CD4+ T cells in human skin by Zanolimumab.
Villadsen LS; Skov L; Dam TN; Dagnaes-Hansen F; Rygaard J; Schuurman J; Parren PW; van de Winkel JG; Baadsgaard O
Arch Dermatol Res; 2007 Feb; 298(9):449-55. PubMed ID: 17091277
[TBL] [Abstract][Full Text] [Related]
2. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
3. A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activity.
Rider DA; Havenith CE; de Ridder R; Schuurman J; Favre C; Cooper JC; Walker S; Baadsgaard O; Marschner S; vandeWinkel JG; Cambier J; Parren PW; Alexander DR
Cancer Res; 2007 Oct; 67(20):9945-53. PubMed ID: 17942927
[TBL] [Abstract][Full Text] [Related]
4. Drug evaluation: zanolimumab, a human monoclonal antibody targeted against CD4.
Assaf C; Sterry W
Curr Opin Mol Ther; 2007 Apr; 9(2):197-203. PubMed ID: 17458175
[TBL] [Abstract][Full Text] [Related]
5. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
[TBL] [Abstract][Full Text] [Related]
7. A novel xenograft model of cutaneous T-cell lymphoma.
Krejsgaard T; Kopp K; Ralfkiaer E; Willumsgaard AE; Eriksen KW; Labuda T; Rasmussen S; Mathiesen AM; Geisler C; Lauenborg B; Becker JC; Zhang Q; Wasik MA; Odum N; Woetmann A
Exp Dermatol; 2010 Dec; 19(12):1096-102. PubMed ID: 20629733
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
[TBL] [Abstract][Full Text] [Related]
9. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
[TBL] [Abstract][Full Text] [Related]
10. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.
Boehncke WH; Ochsendorf FR; Noll S; Urban M; Popp A; Waldherr D; Haunschild J; Litzenburger T
Br J Dermatol; 2005 Oct; 153(4):758-66. PubMed ID: 16181457
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4.
Sharma A; Davis CB; Tobia LA; Kwok DC; Tucci MG; Gore ER; Herzyk DJ; Hart TK
J Pharmacol Exp Ther; 2000 Apr; 293(1):33-41. PubMed ID: 10734150
[TBL] [Abstract][Full Text] [Related]
14. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.
Bachelez H; Flageul B; Dubertret L; Fraitag S; Grossman R; Brousse N; Poisson D; Knowles RW; Wacholtz MC; Haverty TP; Chatenoud L; Bach JF
J Autoimmun; 1998 Feb; 11(1):53-62. PubMed ID: 9480723
[TBL] [Abstract][Full Text] [Related]
16. Density and proportions of the epidermal T cell population in human sun-exposed skin differ from those in sun-protected skin: preliminary immunohistochemical study.
Di Nuzzo S; Pavanello P; De Panfilis G
Arch Dermatol Res; 2009 Mar; 301(3):219-26. PubMed ID: 18615254
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
18. Future directions for pentostatin (Nipent) usage in dermatology.
Heald P
Semin Oncol; 2000 Apr; 27(2 Suppl 5):3-8. PubMed ID: 10877044
[TBL] [Abstract][Full Text] [Related]
19. CD7 expression in reactive and malignant human skin T-lymphocytes.
Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
[TBL] [Abstract][Full Text] [Related]
20. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
